UT to highlight individualized health-care research, treatments at Research Day

April 27, 2011 | Research, UToday
By Jon Strunk

The second annual University of Toledo Health Science Campus Research Day, “Biomarkers, Therapeutics and Individualized Medicine,” will be held Friday, April 29, from 8 a.m. to 2 p.m. in the Dana Center.



Six UT researchers will give presentations on their work, and more than 70 posters outlining ongoing basic, translational and clinical research will be on display. The highlight of the event will be a keynote speech at 1 p.m. by 1998 Nobel Prize winner in medicine Dr. Ferid Murad.

“We’re no longer just researching how to treat cancer or migraines. We’re researching how to treat individual patient migraines, which may well be a little different for every patient,” said Dr. Jeffrey Gold, chancellor and executive vice president for biosciences and health affairs and dean of the College of Medicine and Life Sciences.

Following opening remarks at 8 a.m. by Dr. Debra Gmerek, associate dean of research in the College of Medicine and Life Sciences, the schedule will be:

• 8:15 a.m. — “Biomarkers: Blood-Based Strategies to Monitor Metabolic Syndrome, CVD and the Promise of Clinical Application” by Dr. Nader Abraham, professor and chair of the Physiology and Pharmacology Department in the College of Medicine and Life Sciences;

• 8:40 a.m. — “2-Deoxyribose Fragments as Biomarkers of Oxidative Stress” by Dr. Amanda Bryant-Fredrich, associate professor of medicinal and biological chemistry in the College of Pharmacy and Pharmaceutical Sciences;

• 9:05 a.m. — “Factors Differentiating Wanderers and Non-Wanderers Among Nursing Home Residents With Dementia” by Dr. Donna L. Algase, associate dean of research and evaluation in the College of Nursing;

• 9:45 a.m. — “Migraine and Biomarkers of Endothelial Activation” by Dr. Gretchen Tietjen, professor and chair of the Department of Neurology in the College of Medicine and Life Sciences;

• 10:10 a.m. — “Mechanistic Insights Into Cytoskeletal Dynamics During Cancer Cell Motility” by Dr. Kathryn Eisenmann, assistant professor of biochemistry and cancer biology in the College of Medicine and Life Sciences;

• 10:35 a.m. — “Prospective Multi-Site Clinical Validation Trial of a Long Cancer Risk Test” by Dr. James Willey, professor of medicine in the College of Medicine and Life Sciences;

• 11 a.m. to 1 p.m. – Poster viewing and lunch; and

• 1 p.m. — “Nitric Oxide and Cyclic GMP in Cancer and Stem Cells Revisited” by Dr. Ferid Murad.

Physicians will be able to earn continuing medical education credit of up to 3.5 hours for $35. Registration will be offered at the event.

The Health Sciences Research Day is sponsored by the UT Physiology and Pharmacology Department and the Jacobson Center for Clinical & Translational Research with support from UT Innovation Enterprises, Mettler Toledo and Rainin Instrument Co. It was organized by Gmerek and Dr. Bryan Yamamoto, professor and chair of the Department of Neurosciences.

Click to access the login or register cheese